Biotech & Life Sciences 2026Updated

List of Regulated Clinical Biobank Storage Providers

Directory of biobank storage providers offering GLP, GCLP, and GMP-compliant specimen storage for clinical trials, translational research, and long-term biorepository management across global facilities.

Available Data Fields

Provider Name
Headquarters
Regulatory Compliance
Storage Temperature Range
Certifications
Facility Locations
Sample Types Supported
Biosafety Level
Contact Information
Website

Data Preview

* Full data requires registration
Provider NameHeadquartersRegulatory ComplianceCertifications
Fisher BioServices (Thermo Fisher Scientific)Waltham, MA, USAGMP, GLP, GCPISO 9001, 21 CFR Part 11
Azenta Life SciencesBurlington, MA, USAGTP, GMP, GCLPISO 9001, ISO 13485, CAP
Cryoport SystemsNashville, TN, USAGMP, GCP, GCLP, GDPISO 9001, ISO 20387
Sampled (formerly Infinity BiologiX)Piscataway, NJ, USAGLP, GCLP, GCPCAP, CLIA, ISO 20387
Patheon (Thermo Fisher Scientific)Durham, NC, USAcGMPISO 9001, FDA Registered

300+ records available for download.

* Continue from free preview

Regulated Clinical Biobank Storage: A Critical Infrastructure for Modern Clinical Research

Clinical biobanking has evolved from a simple specimen storage function into a highly regulated, quality-critical component of drug development and translational research. With the global biobanking market projected to exceed $160 billion by 2034, the demand for outsourced, regulation-compliant biorepository services continues to accelerate — driven by the growth of cell and gene therapies, precision medicine trials, and multi-site global studies requiring harmonized sample handling.

Key Regulatory Frameworks

GLP (Good Laboratory Practice)
Defined under 21 CFR Part 58, GLP governs non-clinical safety studies. Biobanks supporting preclinical programs must maintain GLP-compliant chain of custody, environmental monitoring, and audit trails.
GCLP (Good Clinical Laboratory Practice)
Bridges GLP and GCP principles for clinical trial laboratory operations. GCLP compliance ensures that biomarker, pharmacokinetic, and immunogenicity samples are handled with clinical-grade rigor.
GMP (Good Manufacturing Practice)
Required for storage of investigational products, cell therapies, and biologics. GMP biorepositories operate under validated SOPs with environmental qualification and 21 CFR Part 11-compliant data systems.

Critical Selection Criteria

FactorWhat to Evaluate
Temperature RangeCryogenic (-196°C LN₂) through controlled ambient; verify validated qualification protocols
AccreditationsCAP Biorepository Accreditation, ISO 20387, ISBER Best Practices compliance
Data Integrity21 CFR Part 11-compliant LIMS, real-time monitoring, automated audit trails
Biosafety LevelBSL-1 through BSL-3 capacity for infectious or high-risk specimens
Global FootprintMulti-site redundancy, cross-border shipping permits, GDP-compliant logistics

Emerging Trends

Automated cryogenic storage systems are reducing human error in sample retrieval, while blockchain-based chain-of-custody solutions are gaining traction for regulatory submissions. The rise of decentralized clinical trials has increased demand for regional biobanking nodes that can process and store specimens closer to collection sites, reducing transit times and improving sample viability.

Frequently Asked Questions

Q.How is provider compliance data verified?

At the time of your request, our AI crawls each provider's public disclosures — including accreditation databases (CAP, ISO registries), FDA establishment registrations, and published quality documentation — to compile current compliance status from publicly available sources.

Q.Does this dataset include pricing or contract terms?

No. Storage pricing is typically negotiated based on volume, sample type, duration, and service level. This dataset provides the operational and compliance profile needed to build a qualified shortlist before engaging in RFP processes.

Q.Can I filter by specific sample types like FFPE tissue or viable cells?

Yes. You can specify sample types in your request — including FFPE blocks, viable cells, whole blood, plasma, DNA/RNA extracts, or cell therapy products — and the dataset will reflect each provider's validated capabilities for those specimen categories.

Q.How current is the regulatory certification data?

Data is collected from public web sources at the time of your request, not from a static database. Accreditation and certification statuses reflect what each provider publicly discloses. We recommend confirming critical certifications directly with the provider before contract execution.